Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
Kanqiu Jiang,* Mingjing Shen,* Weihua Xu Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou Shi, Jiangsu Sheng, People’s Republic of China *These authors contributed equally to this work Purpose: In this study, a novel arginine, glycine, a...
Main Authors: | Jiang K, Shen M, Xu W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/arginine-glycine-aspartic-acid-peptide-modified-paclitaxel-and-curcumi-peer-reviewed-article-IJN |
Similar Items
-
Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
by: Zhu R, et al.
Published: (2017-12-01) -
Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy
by: Wang WY, et al.
Published: (2019-07-01) -
Curcumin improved liposomal mitomycin-induced cell toxicity in bladder cancer cell
by: Farjad Amanolahi, et al.
Published: (2018-10-01) -
OBTAINING AND CHARACTERISTIC OF CURCUMIN LIPOSOMAL FORM
by: Shulga S. M.
Published: (2014-10-01) -
In Vitro Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer
by: Sara Yousefi Aldashi, et al.
Published: (2021-02-01)